Biogen, Inc.-0.323 %

Daily Stock Price

CEO

Michel Vounatsos


Company Symbol

BIIB


Exchange

NASDAQ


Industry

Biotechnology


Information

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.


*latest update 2020-05-13

Monthly Stock Price

Financial Ratios

Institutional Holders

HolderSharesDate Reported% OutValue
Blackrock Inc.16,043,037Mar 30, 20209.83%5,075,696,046
Primecap Management Company15,965,989Mar 30, 20209.78%5,051,319,599
Vanguard Group, Inc. (The)14,238,227Mar 30, 20208.73%4,504,690,258
State Street Corporation8,262,242Mar 30, 20205.06%2,614,008,123
Renaissance Technologies, LLC4,473,912Mar 30, 20202.74%1,415,456,278
ClearBridge Investments, LLC4,407,311Mar 30, 20202.70%1,394,385,054
Price (T.Rowe) Associates Inc4,284,557Mar 30, 20202.63%1,355,548,143
Wellington Management Company, LLP4,095,239Mar 30, 20202.51%1,295,651,714
Geode Capital Management, LLC3,372,294Mar 30, 20202.07%1,066,926,375
Northern Trust Corporation2,470,802Mar 30, 20201.51%781,712,336

Search a Stock from the NASDAQ 100

We are redirecting you to